EGFR-IN-5

CAS No. 2225887-26-1

EGFR-IN-5( —— )

Catalog No. M26191 CAS No. 2225887-26-1

EGFR-IN-5 is a selective inhibitor of EGFR. The IC50s for EGFR, EGFR(L858R), EGFR(L858R/T790M), and EGFR(L858R/T790M/C797S) are 10.4, 1.1, 34, 7.2 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 315 In Stock
5MG 250 In Stock
10MG 398 In Stock
25MG 753 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EGFR-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    EGFR-IN-5 is a selective inhibitor of EGFR. The IC50s for EGFR, EGFR(L858R), EGFR(L858R/T790M), and EGFR(L858R/T790M/C797S) are 10.4, 1.1, 34, 7.2 nM, respectively.
  • Description
    EGFR-IN-5 is a selective inhibitor of EGFR. The IC50s for EGFR, EGFR(L858R), EGFR(L858R/T790M), and EGFR(L858R/T790M/C797S) are 10.4, 1.1, 34, 7.2 nM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2225887-26-1
  • Formula Weight
    571.705
  • Molecular Formula
    C31H38FN9O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)C1CCN(CC1)c1ccc(Nc2cc3c(nc(Nc4ccc(F)cc4)nc3cn2)N2CCC(CO)CC2)nc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.PANSY FE, et al. In vitro studies with 1-hydroxy-2(1H) pyridinethione. Proc Soc Exp Biol Med. 1953 Jan;82(1):122-4.
molnova catalog
related products
  • Glaucocalyxin A

    Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.

  • Withanolide A

    Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans.

  • Simotinib

    Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.